CONSIDER
- ACEIs are indicated as first line treatment in patients with LVEF<40% regardless of symptoms
- ARBs are indicated as second line agents if ACEIs are not tolerated (eg. cough, allergy)
- Combination ACEI+ARB should only be considered if the benefits outweigh the risks and close monitoring can be achieved.